rss
Br J Ophthalmol 2009;93:1151-1154 doi:10.1136/bjo.2008.153908
  • Global issues

RPGR ORF15 genotype and clinical variability of retinal degeneration in an Australian population

  1. J B Ruddle1,2,
  2. N D Ebenezer3,
  3. L S Kearns1,
  4. L E Mulhall2,
  5. D A Mackey1,2,
  6. A J Hardcastle3
  1. 1
    Centre for Eye Research Australia, East Melbourne, Australia
  2. 2
    Ocular Diagnostic Clinic, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia
  3. 3
    UCL Institute of Ophthalmology, London, UK
  1. Correspondence to Dr J Ruddle, Centre for Eye Research Australia, 32 Gisborne St, East Melbourne 3002, Australia; jbruddle{at}gmail.com
  • Accepted 24 April 2009
  • Published Online First 7 May 2009

Abstract

Background: Mutations in the retinitis pigmentosa GTPase regulator gene (RPGR) are estimated to cause up to 20% of all Caucasian retinitis pigmentosa and up to 75% of cases of X-Linked RP (XLRP). Exon open reading frame 15 (ORF15) is a purine-rich mutation hotspot. Mutations in RPGR ORF15 have also been documented to cause X linked cone–rod dystrophy (XLCORD) and atrophic macular degeneration at an unknown frequency.

Methods: From a hospital clinic population, probands with probable XLRP and XLCORD were screened for RPGR ORF15 mutations and fully phenotyped.

Results: Four different RPGR ORF15 mutations were found in four probands. All mutations in the ORF15 exon resulted in premature truncation of the RPGR protein. Three were nonsense mutations: c.507G>T (p.E169stop), c.867G>T (p.G289stop), c.897G>T (p.E299stop) and the fourth a single nucleotide insertion c.1558–1559insA (p.S522fs 525stop). One family exhibited typical XLRP, two XLCORD and one a combination of the phenotypes.

Conclusion: RPGR ORF15 mutations produce intrafamilial and interfamilial clinical variability with varying degrees of cone degeneration. In an Australian clinic population RPGR ORF15 mutations cause XLCORD in addition to XLRP.

Footnotes

  • Funding This research was supported by grant 065454/Z/01/Z from the Wellcome Trust.

  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed.

  • Ethics approval Ethics approval was provided by the Royal Victorian Eye and Ear Hospital, Melbourne.

  • Patient consent Obtained.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.